DongKoo Bio & Pharma Co., Ltd. (KOSDAQ:006620)
South Korea
· Delayed Price · Currency is KRW 5,110.00
-270.00 (-5.02%)
At close: Mar 9, 2026
DongKoo Bio & Pharma Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2017 |
| Market Capitalization | 138,185 | 131,049 | 156,349 | 169,609 | 232,556 | 240,580 | Upgrade
|
| Market Cap Growth | 1.63% | -16.18% | -7.82% | -27.07% | -3.33% | - | Upgrade
|
| Enterprise Value | 222,691 | 172,921 | 172,036 | 175,056 | 221,869 | 244,593 | Upgrade
|
| Last Close Price | 5110.00 | 4694.12 | 5398.48 | 5731.92 | 7541.16 | 7564.67 | Upgrade
|
| PE Ratio | 179.53 | 64.38 | 13.24 | 25.64 | 24.94 | 26.32 | Upgrade
|
| PS Ratio | 0.58 | 0.53 | 0.73 | 0.87 | 1.50 | 1.73 | Upgrade
|
| PB Ratio | 1.25 | 1.24 | 1.42 | 1.66 | 2.32 | 2.54 | Upgrade
|
| P/TBV Ratio | 1.31 | 1.42 | 1.57 | 1.82 | 2.40 | 2.60 | Upgrade
|
| P/FCF Ratio | - | - | - | 14.32 | 17.05 | 108.33 | Upgrade
|
| P/OCF Ratio | - | 7.56 | 43.61 | 10.08 | 12.99 | 32.13 | Upgrade
|
| EV/Sales Ratio | 0.93 | 0.69 | 0.80 | 0.90 | 1.43 | 1.76 | Upgrade
|
| EV/EBITDA Ratio | 15.00 | 8.66 | 8.33 | 7.79 | 16.82 | 20.19 | Upgrade
|
| EV/EBIT Ratio | 37.30 | 13.63 | 11.77 | 10.40 | 27.26 | 32.14 | Upgrade
|
| EV/FCF Ratio | -11.99 | - | - | 14.78 | 16.27 | 110.14 | Upgrade
|
| Debt / Equity Ratio | 0.97 | 0.82 | 0.40 | 0.34 | 0.24 | 0.25 | Upgrade
|
| Debt / EBITDA Ratio | 7.21 | 4.34 | 2.12 | 1.53 | 1.84 | 1.96 | Upgrade
|
| Debt / FCF Ratio | - | - | - | 2.90 | 1.78 | 10.69 | Upgrade
|
| Net Debt / Equity Ratio | 0.76 | 0.48 | 0.19 | -0.01 | -0.08 | -0.06 | Upgrade
|
| Net Debt / EBITDA Ratio | 5.69 | 2.52 | 1.01 | -0.04 | -0.59 | -0.48 | Upgrade
|
| Net Debt / FCF Ratio | -4.55 | -11.14 | -2.04 | -0.07 | -0.57 | -2.63 | Upgrade
|
| Asset Turnover | 0.94 | 1.15 | 1.19 | 1.19 | 1.04 | - | Upgrade
|
| Inventory Turnover | 1.98 | 2.20 | 2.26 | 2.74 | 2.52 | - | Upgrade
|
| Quick Ratio | 0.41 | 0.50 | 0.61 | 0.83 | 0.97 | 1.17 | Upgrade
|
| Current Ratio | 0.93 | 0.93 | 1.21 | 1.32 | 1.48 | 1.79 | Upgrade
|
| Return on Equity (ROE) | 0.63% | 1.84% | 11.11% | 6.54% | 9.58% | - | Upgrade
|
| Return on Assets (ROA) | 1.47% | 3.65% | 5.03% | 6.44% | 3.40% | - | Upgrade
|
| Return on Invested Capital (ROIC) | 3.08% | 4.61% | 10.07% | 14.53% | 7.40% | 10.35% | Upgrade
|
| Return on Capital Employed (ROCE) | 4.00% | 9.90% | 12.40% | 15.90% | 7.80% | 7.30% | Upgrade
|
| Earnings Yield | 0.56% | 1.55% | 7.56% | 3.90% | 4.01% | 3.80% | Upgrade
|
| FCF Yield | -13.44% | -3.45% | -6.56% | 6.98% | 5.86% | 0.92% | Upgrade
|
| Payout Ratio | 421.26% | 162.74% | 25.72% | 42.39% | 10.11% | 10.32% | Upgrade
|
| Buyback Yield / Dilution | -1.26% | 1.13% | 0.48% | 1.78% | 0.12% | -25.96% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.